Cite Filings / SNDX / 0001950047-25-005995
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
144

Sale of Securities

Syndax Pharmaceuticals Inc · Filed 2025-08-18 · Acc 0001950047-25-005995

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2025-09-08 144 Sale of Securities
  • 2025-08-18 144 Sale of Securities
  • 2025-08-18 4 Director sold 57,600 shares at an average $15.19 ($875,100)
  • 2025-08-18 SCHEDULE 13G Statement of Beneficial Ownership
  • 2025-08-14 144 Sale of Securities
  • 2025-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-08-13 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…